SEC Form 4 · accession 0001698665-26-000007
Altimmune, Inc. · ALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jerome Benedict Durso
Officer — President and CEO · Director
Period of report
Aug 13, 2026
Accepted (ET)
Aug 13, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001326190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 | Aug 13, 2026 | P | 15,000 | $2.95 | A | 62,500 | D |
Table II — derivative securities
No Table II lines on this filing.